Welcome to Lab Test Consult

You can log in and post your comments

Share your knowledge and experience!

Member Login
Lost your password?

Gene Study Sheds Light on Body Clock’s Link to Diabetes

January 31, 2012


MONDAY, Jan. 30 (HealthDay News) — Researchers studying the link
between diabetes and a hormone that affects your so-called “body clock”
have identified a genetic mutation in the receptor for the hormone,
melatonin, that may to boost the risk of the disease.

The finding could help improve assessment of a person’s diabetes risk
and could also lead to the development of personalized treatments,
according to the study published in the Jan. 29 online edition of the
journal Nature Genetics.

The research team from Imperial College London found that people who
have rare genetic mutations in the receptor for melatonin have a greatly
increased risk for type 2 diabetes.

Melatonin controls the body’s sleep-wake cycle. A previous study found
that people with common variations in the gene for the melatonin receptor
MT2 have a slightly increased risk for type 2 diabetes.

This new study discovered that having any of four rare mutations of the
MT2 is associated with a six times increased risk of developing type 2

Melatonin controls the release of insulin, which regulates blood sugar
levels. Mutations in the MT2 gene may disrupt the connection between the
body clock and insulin release, resulting in abnormal control of blood
sugar, the researchers explained.

For their study, the investigators examined the MT2 gene in more than
7,000 people. They identified 40 variants associated with type 2 diabetes,
four of which are very rare and make the receptor incapable of responding
to melatonin. The effect of these four variants was then confirmed in an
additional group of nearly 12,000 people.

“Blood sugar control is one of the many processes regulated by the
body’s biological clock. This study adds to our understanding of how the
gene that carries the blueprint for a key component in the clock can
influence people’s risk of diabetes,” study leader Philippe Froguel, from
the School of Public Health, said in an Imperial College London news

“We found very rare variants of the MT2 gene that have a much larger
effect than more common variants discovered before. Although each mutation
is rare, they are common in the sense that everyone has a lot of very rare
mutations in their DNA. Cataloging these mutations will enable us to much
more accurately assess a person’s risk of disease based on their
genetics,” Froguel added.

While the study found a link between the mutation and diabetes risk, it
did not find a cause-and-effect relationship.


Related posts:

  1. First gene-link to inherited prostate cancer
  2. 'First gene link' to inherited prostate cancer
  3. Light-ning Fast Diabetes Test
  4. Wash U Med School Offers 28-Gene Cancer Dx Panel on HiSeq through CLIA Lab
  5. Diabetes drug shows promise in reducing risk of cancer, study suggests
  6. Breast Cancer Gene Puts Survivors at Higher Odds for Recurrence
  7. Pro-life advocates: Study shows link between breast cancer and abortion; cancer institute: no way
  8. Risk for Dementia Rises When Diabetes, Depression Meet: Study
  9. Diabetes Takes a Toll on Lifetime Earnings: Study
  10. Intensive Control of Type 1 Diabetes Helps Kidneys: Study

New post


February 2019
« Aug    


Recent comments

    Contact Sign In

    Email Marketing You Can Trust